{"AllianceGenome": "19832", "HGNC": "19832", "MIM": "616845", "_id": "161198", "_version": 1, "accession": {"genomic": ["AL161751.3", "CH471078.2", "CP068264.2", "NC_000014.9", "NC_060938.1"], "protein": ["AAF28963.1", "AAH31567.2", "AAQ88761.1", "AAS77882.1", "AAT92280.1", "CAD62342.1", "EAW65835.1", "NP_778230.1", "Q86T13.1"], "rna": ["AF161403.1", "AY358395.1", "AY573061.1", "AY606132.1", "BC031567.1", "BX248017.1", "BX423057.2", "NM_175060.3"], "translation": [{"protein": "NP_778230.1", "rna": "NM_175060.3"}, {"protein": "AAS77882.1", "rna": "AY573061.1"}, {"protein": "AAQ88761.1", "rna": "AY358395.1"}, {"protein": "AAF28963.1", "rna": "AF161403.1"}, {"protein": "AAH31567.2", "rna": "BC031567.1"}, {"protein": "CAD62342.1", "rna": "BX248017.1"}, {"protein": "AAT92280.1", "rna": "AY606132.1"}]}, "alias": ["C14orf27", "CEG1", "EGFR-5"], "ensembl": {"gene": "ENSG00000176435", "protein": "ENSP00000353013", "transcript": "ENST00000342213", "translation": [{"protein": "ENSP00000353013", "rna": "ENST00000342213"}], "type_of_gene": "protein_coding"}, "entrezgene": "161198", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 8.97997299, "exp_mis": 251.4966277, "exp_syn": 140.1446, "lof_z": 0.98506411394838, "mis_z": 2.9762020302145, "mu_lof": 7.55579795121e-07, "mu_mis": 2.21600069102e-05, "mu_syn": 1.23321195389e-05, "n_lof": 6.0, "n_mis": 155.0, "n_syn": 92.0, "p_li": 0.000668541235966075, "p_null": 0.257447623261634, "p_rec": 0.7418838355024, "syn_z": 2.52120878372083}, "bp": 1473, "cds_end": 38725227, "cds_start": 38723754, "n_exons": 1, "nonpsych": {"exp_lof": 8.1071067, "exp_mis": 227.6080885, "exp_syn": 126.8237423, "lof_z": 1.07170489407514, "mis_z": 2.9289508866116, "mu_lof": 7.55579795121e-07, "mu_mis": 2.21600069102e-05, "mu_syn": 1.23321195389e-05, "n_lof": 5.0, "n_mis": 140.0, "n_syn": 86.0, "p_li": 0.00307067905502189, "p_null": 0.204249258749414, "p_rec": 0.792680062195564, "syn_z": 2.28231572067788}, "nontcga": {"exp_lof": 8.25956428, "exp_mis": 231.3749036, "exp_syn": 128.93101735, "lof_z": 0.775581387423317, "mis_z": 2.79628810213578, "mu_lof": 7.55579795121e-07, "mu_mis": 2.21600069102e-05, "mu_syn": 1.23321195389e-05, "n_lof": 6.0, "n_mis": 146.0, "n_syn": 83.0, "p_li": 0.00048387852331022, "p_null": 0.32458913157896, "p_rec": 0.67492698989773, "syn_z": 2.56123552553745}, "transcript": "ENST00000342213.2"}, "exons": [{"cdsend": 38256022, "cdsstart": 38254549, "chr": "14", "position": [[38253999, 38256093]], "strand": -1, "transcript": "NM_175060", "txend": 38256093, "txstart": 38253999}], "exons_hg19": [{"cdsend": 38725227, "cdsstart": 38723754, "chr": "14", "position": [[38723204, 38725298]], "strand": -1, "transcript": "NM_175060", "txend": 38725298, "txstart": 38723204}], "generif": [{"pubmed": 21706054, "text": "In this study, they identify and characterize a novel tumor endothelial marker, CLEC14A, which has properties that suggest it is a candidate for tumor vascular targeting and anti-angiogenic approaches."}, {"pubmed": 23644659, "text": "clec14a-CTLD may be a key domain in angiogenesis"}, {"pubmed": 23979707, "text": "CLEC14A is a matrix component which binds to MMRN2 in the process of endothelial cells transformation in tumor angiogenesis."}, {"pubmed": 25745997, "text": "Results suggest that CLEC14A-MMRN2 binding has a role in inducing sprouting angiogenesis during tumor growth, which has the potential to be manipulated in future antiangiogenic therapy design."}, {"pubmed": 25745997, "text": "The CLEC14A-MMRN2 interaction is involved in sprouting angiogenesis. Disrupting this interaction with monoclonal antibodies directed against CLEC14A show anti-angiogenic and anti-tumor effects."}, {"pubmed": 28671670, "text": "These findings identify novel protein interactions involving CLEC14A, CD93 and CD248 with MMRN2 as targetable components of vessel formation"}, {"pubmed": 30132150, "text": "Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer."}, {"pubmed": 30191970, "text": "CLEC14A acts as an antitumor role in lung adenocarcinoma (LUAD) by suppressing cell proliferation, migration, invasion, promoting cell apoptosis, and reducing tumorigenicity in nude mice. Thus, the inhibition of CLEC14A methylation is a novel strategy for the clinic treatment of LUAD"}, {"pubmed": 31852888, "text": "Study identified PAX7-negative human muscle-derived cell colonies also positive for the myogenic markers desmin and MYF5 and reveal the endothelial cell marker CLEC14A to be highly expressed in PAX7null cells. Transplanted PAX7neg cells repopulate the satellite cell niche where they re-express PAX7, or, strikingly, CLEC14A. In conclusion, transplanted human cells do not depend on PAX7 for muscle regeneration."}, {"pubmed": 31964714, "text": "Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein."}, {"pubmed": 32696621, "text": "An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours."}, {"pubmed": 35576868, "text": "CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker."}], "genomic_pos": {"chr": "14", "end": 38256093, "ensemblgene": "ENSG00000176435", "start": 38254000, "strand": -1}, "genomic_pos_hg19": {"chr": "14", "end": 38725574, "start": 38723308, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001946", "qualifier": "involved_in", "term": "lymphangiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002042", "qualifier": "involved_in", "term": "cell migration involved in sprouting angiogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0016477", "qualifier": "involved_in", "term": "cell migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0036324", "pubmed": 27991863, "qualifier": "involved_in", "term": "vascular endothelial growth factor receptor-2 signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0036325", "pubmed": 27991863, "qualifier": "involved_in", "term": "vascular endothelial growth factor receptor-3 signaling pathway"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0009897", "qualifier": "is_active_in", "term": "external side of plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009897", "pubmed": 25745997, "qualifier": "is_active_in", "term": "external side of plasma membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0062023", "pubmed": 23979707, "qualifier": "located_in", "term": "collagen-containing extracellular matrix"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [27991863, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0030246", "qualifier": "enables", "term": "carbohydrate binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0050840", "qualifier": "enables", "term": "extracellular matrix binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:1990430", "qualifier": "enables", "term": "extracellular matrix protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990430", "pubmed": 25745997, "qualifier": "enables", "term": "extracellular matrix protein binding"}]}, "homologene": {"genes": [[9544, 698253], [9598, 467435], [9606, 161198], [9615, 490660], [9913, 509367], [10090, 66864], [10116, 314148]], "id": 12047}, "interpro": [{"desc": "C-type lectin-like", "id": "IPR001304", "short_desc": "C-type_lectin-like"}, {"desc": "C-type lectin-like/link domain superfamily", "id": "IPR016186", "short_desc": "C-type_lectin-like/link_sf"}, {"desc": "C-type lectin fold", "id": "IPR016187", "short_desc": "CTDL_fold"}], "ipi": "IPI00240345", "map_location": "14q21.1", "name": "C-type lectin domain containing 14A", "other_names": ["C-type lectin domain family 14 member A", "ClECT and EGF-like domain containing protein", "epidermal growth factor receptor 5"], "pantherdb": {"HGNC": "19832", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1914114", "ortholog_type": "LDO", "panther_family": "PTHR14789", "taxid": 10090, "uniprot_kb": "Q8VCP9"}, {"RGD": "1306232", "ortholog_type": "LDO", "panther_family": "PTHR14789", "taxid": 10116, "uniprot_kb": "Q642B4"}, {"ZFIN": "ZDB-GENE-030131-2084", "ortholog_type": "O", "panther_family": "PTHR14789", "taxid": 7955, "uniprot_kb": "A0A0R4IKQ6"}, {"ZFIN": "ZDB-GENE-050309-46", "ortholog_type": "O", "panther_family": "PTHR14789", "taxid": 7955, "uniprot_kb": "E9QBZ7"}], "uniprot_kb": "Q86T13"}, "pharmgkb": "PA134890576", "pharos": {"target_id": 17398, "tdl": "Tbio"}, "prosite": "PS50041", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF174878", "relationship": "is"}, {"id": "GNF185784", "relationship": "is"}, {"id": "GNF196690", "relationship": "is"}, {"id": "GNF207596", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF162589", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF047868", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": {"id": "GNF092541", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": {"id": "GNF074459", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF001422", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF237424", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF102171", "relationship": "is"}, {"id": "GNF141826", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000014.9", "NC_060938.1"], "protein": "NP_778230.1", "rna": "NM_175060.3", "translation": {"protein": "NP_778230.1", "rna": "NM_175060.3"}}, "reporter": {"GNF1H": "gnf1h14385_at", "HG-U133_Plus_2": "226244_at", "HTA-2_0": "TC14001061.hg.1", "HuEx-1_0": "3561868", "HuGene-1_1": "7978712", "HuGene-2_1": "16792211"}, "summary": "This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting. [provided by RefSeq, Jan 2012].", "symbol": "CLEC14A", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1539107"}, "unigene": "Hs.525307", "uniprot": {"Swiss-Prot": "Q86T13"}}